HCPCS E1390: Oxygen Concentrator, Single Delivery Port
HCPCS Level II code E1390 identifies a stationary oxygen concentrator with a single delivery port capable of providing 85% or greater oxygen concentration at the prescribed flow rate. This equipment is central to long-term oxygen therapy for patients with hypoxemia and respiratory failure and influences durable medical equipment coverage, home health planning, and respiratory care resource allocation nationally.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, United Healthcare, and Medicare. Readers will find a concise overview of clinical context, common diagnostic justifications, related supply and rental codes, and payer coverage contours. The publication summarizes typical sites of service and the role of the device in outpatient and home-based respiratory care.
The report provides benchmarks for utilization and billing relationships among related oxygen equipment codes, highlights common ICD-10 diagnoses that map to long-term oxygen therapy, and outlines coding relationships that affect claims processing. Policy and reimbursement update summaries are included where available; if specific payer policy details are not provided in the input, the text notes that data is not available in the input. The content is designed to help coding, billing, and clinical operations teams understand the purpose and billing context of HCPCS Level II code E1390 in a national scope.
Customize your policy alerts
Sign up for hcpcs E1390 policy alerts
Get alerted when payer policies referencing E1390 are released or updated.
Monitor payer policy activity
Billing Code Overview
HCPCS Level II code E1390 describes an oxygen concentrator with a single delivery port that is capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate. This device is classified as durable medical equipment intended to provide continuous or intermittent supplemental oxygen to patients with hypoxemia or respiratory failure.
Service Type: Durable medical equipment — stationary home oxygen concentrator
Typical Site of Service: Home or other outpatient/residential settings where long-term oxygen therapy is administered
National Reimbursement Benchmarks
National commercial reimbursement for HCPCS E1390 centers around BUCA’s average commercial rate of $483.80, with individual payers showing meaningful variation around that benchmark. Blue Cross Blue Shield exhibits the largest upper spread with a P75−P25 range of $474.60 ($702.40 − $242.80), and Cigna shows a relatively wide interquartile spread of $690.40 ($750.60 − $60.80). Aetna’s interquartile range is $661.30 ($750.20 − $88.90), while UnitedHealth Group is the tightest among the listed payers with a P75−P25 range of $366.00 ($442.80 − $63.80).
In absolute terms, Blue Cross Blue Shield and Cigna present the widest IQR-based dispersion, indicating the most variability in commercial placements, while UnitedHealth Group most tightly clusters around its middle 50%. BUCA’s mean at $483.80 sits near the mid-to-upper portion of payer means, reflecting its role as an average commercial benchmark in this market context.